Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Heilongjiang Letai Pharmaceutical Co., Ltd. is a prominent Chinese pharmaceutical company specializing in the research, development, and large-scale manufacturing of over-the-counter (OTC) medicines and Traditional Chinese Medicines (TCM). The company is most famous for its flagship brand, Liangjia (亮甲), which has maintained a leading market share in China for the treatment of onychomycosis and other fungal skin infections for over two decades. Beyond dermatology, Letai produces an extensive portfolio of products targeting respiratory health, digestive ailments, and pediatric care. The company operates advanced GMP-certified production facilities in Harbin and maintains a robust retail distribution network across mainland China. Letai is recognized as a high-tech enterprise and a significant contributor to the modernization of traditional herbal formulations into standardized pharmaceutical products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 乐泰药业.